Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study. (Q51289170)
Jump to navigation
Jump to search
scientific article published in January 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study. |
scientific article published in January 2013 |
Statements
Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study. (English)
1 reference
1 reference
1 reference
Amirhossein Modabbernia
1 reference
Farzin Rezaei
1 reference
Morteza Jafarinia
1 reference
Mandana Ashrafi
1 reference
Mina Tabrizi
1 reference
Seyed M R Hosseini
1 reference
Ali Ghaleiha
1 reference
1 January 2013
1 reference
27
1 reference
1
1 reference
57-65
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference